News | March 31, 2014

BioCardia Receives CE Mark for Morph AccessPro Steerable Introducer


March 31, 2014 — BioCardia Inc. announced it received CE mark for its Morph AccessPro steerable introducer, designed for easier navigation through the vasculature during delivery of biotherapeutics and medical devices.

The steerable thin-walled catheter shaft technology provides a flexible pathway for biologic delivery systems, balloon dilatation catheters, stents, guidewires and micro infusion systems. The unique introducer is designed to enhance physician control and reduce complications and catheter exchanges, minimizing procedure time and radiation exposure. It will be commercially available in the European Union in the coming months.

“Many times, the primary reason for failure of a particular procedure is the inability to gain access into the aortic branches with a guide catheter or guide sheath,” said Rodney S. Badger, M.D., chief of interventional cardiology and associate professor of medicine for the University of Utah. “This introducer is valuable today to improve access for aorto-ostial procedures, thereby enhancing safety and shortening procedure times. It also has future potential to enhance biotherapeutic interventions for diseases of the organs fed by these arteries, such as inflammatory bowel diseases, renal diseases and even diseases involving the pancreas.”

Current commercially available guide catheters have pre-formed distal curves shaped like a “hockey stick” or a “shepherd’s crook,” designed to maneuver within specific vascular anatomical configurations. If a patient’s anatomy is complicated and does not match the catheter shape, access can be time-consuming and difficult to achieve.

The Morph AccessPro enables a physician to customize the catheter shape to an individual patient’s anatomy, allowing access to the contra-lateral superficial femoral artery (SFA) all the way down to the trifurcation, the renal arteries and the mesenteric arteries.

The Morph AccessPro is currently being used commercially in 350 U.S. hospitals and has been used in thousands of cases to date.

For more information: www.biocardia.com


Related Content

Feature | Vascular Access | Dave Fornell, Editor

Vascular access site bleeding is associated with higher complications and mortality rates. For decades femoral access ...

Home June 10, 2020
Home
News | Vascular Access

June 8, 2020 – BD (Becton, Dickinson and Company) launched the Halo One Thin-Walled Guiding Sheath, designed to perform ...

Home June 08, 2020
Home
News | Vascular Access

November 6, 2019 — Saranas Inc. announced completion of the first U.S. commercial case using its Early Bird Bleed ...

Home November 07, 2019
Home
Technology | Vascular Access

September 3, 2019 — New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically driven ...

Home September 03, 2019
Home
News | Vascular Access

May 31, 2019 — Terumo Medical Corp. is recalling the SoloPath Balloon Expandable TransFemoral System and Re-Collapsible ...

Home May 31, 2019
Home
News | Vascular Access

October 4, 2017 — TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European ...

Home October 04, 2017
Home
News | Vascular Access

March 31, 2017 — The U.S. Food and Drug Administration (FDA) announced it has initiated a Class I recall of the Merit ...

Home March 31, 2017
Home
News | Vascular Access

January 31, 2017 — Bard Peripheral Vascular Inc. is recalling the Halo One Thin-Walled Guiding Sheath because the sheath ...

Home January 31, 2017
Home
Technology | Vascular Access

January 10, 2017 — Teleflex Inc. announced that its Arrow VPS Rhythm Device with optional TipTracker technology has been ...

Home January 10, 2017
Home
News | Vascular Access

September 20, 2016 — Teleflex Inc. recently displayed its vascular access technologies and a new educational platform ...

Home September 20, 2016
Home
Subscribe Now